Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -88,093 | -95,059 | -88,447 | -84,713 | -97,090 |
| Depreciation Amortization | -1,749 | -3,612 | 10,425 | -205 | 551 |
| Income taxes - deferred | -681 | N/A | N/A | N/A | N/A |
| Accounts receivable | -675 | 567 | -938 | 256 | 4,181 |
| Accounts payable and accrued liabilities | 2,506 | -1,859 | -2,734 | 2,770 | 1,422 |
| Other Working Capital | 6,752 | 4,478 | -8,274 | 14,111 | -251 |
| Other Operating Activity | 14,405 | 15,637 | 14,158 | 5,195 | 12,949 |
| Operating Cash Flow | $-67,535 | $-79,848 | $-75,810 | $-62,586 | $-78,238 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -132,462 | -28,386 | 13,779 | -73,273 | 99,835 |
| PPE Investments | -11 | N/A | -47 | -126 | -12,117 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -195 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -195 |
| Investing Cash Flow | $-132,473 | $-28,386 | $13,732 | $-73,399 | $87,523 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 35,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 174,065 | 10,894 | 86,929 | 57,297 | 65,216 |
| Other Financing Activity | -2,223 | -850 | -824 | -516 | -118 |
| Financing Cash Flow | $206,842 | $10,044 | $86,105 | $56,781 | $65,098 |
| Beginning Cash Position | 36,968 | 135,158 | 111,131 | 190,335 | 115,952 |
| End Cash Position | 43,802 | 36,968 | 135,158 | 111,131 | 190,335 |
| Net Cash Flow | $6,834 | $-98,190 | $24,027 | $-79,204 | $74,383 |
| Free Cash Flow | |||||
| Operating Cash Flow | -67,535 | -79,848 | -75,810 | -62,586 | -78,238 |
| Capital Expenditure | -11 | N/A | -47 | -126 | -12,117 |
| Free Cash Flow | -67,546 | -79,848 | -75,857 | -62,712 | -90,355 |